4//SEC Filing
Tsai John 4
Accession 0001415889-23-000700
CIK 0001597264other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:16 PM ET
Size
14.6 KB
Accession
0001415889-23-000700
Insider Transaction Report
Form 4
Tsai John
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-06+7,950→ 7,950 totalExercise: $46.87Exp: 2033-01-06→ Common Stock (7,950 underlying) - Award
Common Stock
2023-01-06+3,900→ 3,900 total
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of a grant of 3,900 restricted stock units in accordance with the Issuer's non-employee director compensation policy.
- [F2]This option vests with respect to 1/36th of the shares underlying the option on February 6, 2023 and as to an additional 1/36th of the shares underlying the option each month thereafter.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001960467
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:16 PM ET
- Size
- 14.6 KB